NCT02800759View on ClinicalTrials.gov

Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Knee Pain Intermittent
Interventions
DIETARY_SUPPLEMENT

JOINTRUS®

100% Fatty acid compound with 12.5% Cis-9-cetylmyristoleate

DIETARY_SUPPLEMENT

80% dose of JOINTRUS®

80% Fatty acid compound with 12.5% Cis-9-cetylmyristoleate

DIETARY_SUPPLEMENT

62.4% dose of JOINTRUS®

62.4% Fatty acid compound with 12.5% Cis-9-cetylmyristoleate

DIETARY_SUPPLEMENT

Starch 100%

0% Fatty acid compound with 12.5% Cis-9-cetylmyristoleate

All Listed Sponsors
lead

Seoul National University

OTHER

NCT02800759 - Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain | Biotech Hunter | Biotech Hunter